Alemtuzumab and Sirolimus in Renal Transplantation: Six‐Year Results of a Single‐Arm Prospective Pilot Study

Autor: Sutherland, A. I., Akhtar, M. Z., Zilvetti, M., Brockmann, J., Ruse, S., Fuggle, S. V., Sinha, S., Harden, P., Friend, P. J.
Zdroj: American Journal of Transplantation; March 2014, Vol. 14 Issue: 3 p677-684, 8p
Abstrakt: Kidney transplant patients switched at six months from tacrolimus to sirolimus maintenance therapy, in the context of alemtuzumab induction and low‐dose mycophenolate, demonstrate good graft outcomes and compliance with the allocated therapy.
Databáze: Supplemental Index